Margalida Mateu-Borrás

Margalida Mateu-Borrás

Auto-generated profile, based on publicly available information

Margalida Mateu-Borrás

Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), Universidad de las Islas Baleares and Instituto de Investigación Sanitaria de les Illes Balears (IDISBA), Palma de Mallorca, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in Infection and Immunity
Verified
Journal Article
Open access
MMMargalida Mateu-Borrás
Margalida Mateu-Borrás
SDSpencer R. Dublin
Spencer R. Dublin
JKJason Kang
Jason Kang
HMHunter L. Monroe
Hunter L. Monroe
ESEmel Sen-Kilic
Emel Sen-Kilic
MBMariette Barbier
Mariette Barbier
The incidence of infections attributed to antimicrobial-resistant (AMR) pathogens has increased exponentially over the recent decades reaching 1.27 million deaths worldwide in 2019. Without intervention, these infections are predicted to cause up to 10 million deaths a year and incur costs of up to 100 trillion US dollars globally by 2050. The emergence of AMR bacteria such as the ESKAPEE pathogens, and in particular Pseudomonas aeruginosa and species from the genus Burkholderia , underscores an urgent need for new therapeutic strategies. Monoclonal antibody (mAb) therapy offers a promising alternative to treat and prevent bacterial infections. In this study, we used peptides from highly conserved areas of the bacterial flagellin to generate monoclonal antibodies capable of broad binding to flagellated Gram-negative bacteria. We generated a broadly reactive IgG2bĸ mAb (WVDC-2109) that recognizes P. aeruginosa, Burkholderia sp., and other Gram-negative pathogens of interest. Characterization of the therapeutic potential of this antibody was determined using P. aeruginosa as model. In vitro characterization of WVDC-2109 demonstrated complement-mediated bactericidal activity and enhanced opsonophagocytosis of P. aeruginosa . Prophylactic administration of WVDC-2109 markedly improved survival and outcome in a lethal sepsis model and a sub-lethal murine pneumonia model of P. aeruginosa infection, reducing bacterial burden and inflammation. These findings suggest that WVDC-2109 and similar FliC-targeting antibodies could be valuable in preventing or treating diseases caused by P. aeruginosa as well as other life-threatening diseases of concern. IMPORTANCE: Antimicrobial resistance (AMR) costs hundreds of thousands of lives and billions of dollars annually. To protect the population against these infections, it is imperative to develop new medical countermeasures targeting AMR pathogens like P. aeruginosa and Burkholderia sp. The administration of broadly reactive monoclonal antibodies can represent an alternative to treat and prevent infections caused by multi-drug-resistant bacteria. Unlike vaccines, antibodies can provide protection regardless of the immune status of the infected host. In this study, we generated an antibody capable of recognizing flagellin from P. aeruginosa and B. pseudomallei along with other Gram-negative pathogens of concern. Our findings demonstrate that the administration of the monoclonal antibody WVDC-2109 enhances survival rates and outcomes in different murine models of P. aeruginosa infection. These results carry significant implications in the field given that there are no available vaccines for P. aeruginosa .

5 September 2022 in Urolithiasis
Verified
Journal Article
Open access
PDF file
PGPaula Calvó Garcia
Paula Calvó Garcia
MMMargalida Mateu-Borras
Margalida Mateu-Borras
ACAntonia Costa-Bauza
Antonia Costa-Bauza
SASebastián Albertí
Sebastián Albertí
FGFelix Grases
Felix Grases
The use of double J ureteral stents can lead to several adverse effects, as urinary infection. Bacteria tend to colonize the stent surface, leading to the formation of bacterial biofilms. The presence of urease-producing bacteria increase the urine pH leading to the incrustation and blockage of the stent. On the other hand, these large crystalline masses function as niduses, allowing the attachment of even more bacteria and decreasing its exposure to antibiotics. The aim of this in vitro study was to assess the effect of phytate on the attachment of bacteria to the catheter surface under conditions that favor crystallization. Catheter sections were incubated in a synthetic urine medium (pH 6.5) in the presence or absence of Pseudomonas aeruginosa and phytate. Amount of calcium deposits was measured using an Arsenazo III colorimetric method and the number of attached bacteria to the stent was determined. Differences were assessed using an ANOVA with a Bonferroni post hoc test. The formation of calcium phosphate deposits (brushite and hydroxyapatite) and oxalate crystals (COM), as were as the amount of bacteria decreased when phytate was present. Thus, phytate successfully decreased bacterial adhesion by inhibiting the formation of crystalline deposits.

29 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGM. Trinidad García-Barceló
M. Trinidad García-Barceló
RGRosa M. Gomila
Rosa M. Gomila
AGAlex González-Alsina
Alex González-Alsina
ADAntonio Doménech-Sánchez
Antonio Doménech-Sánchez
BMBiel Martorell
Biel Martorell
MMMargalida Mateu-Borrás
Margalida Mateu-Borrás
Pseudomonas aeruginosa is a primary driver of morbidity and mortality in cystic fibrosis (CF) patients. Throughout the course of infection, P. aeruginosa undergoes significant evolution and adaptation to the dynamic environment of the CF respiratory tract, leading to the emergence of diverse phenotypes. Among the variants that arise during this process are mutations in the regulatory gene lasR. While clinical significance of LasR deficiency is well recognized, current evidence does not fully elucidate the metabolic changes associated with the absence of this master regulator. To address this, we conducted untargeted metabolic profiling of cell supernatants (exometabolomes) to compare twenty-four P. aeruginosa strains, collected over 3–8 years from ten CF patients classified either as LasR functional (LasR+) or LasR non-functional (LasR−). We found a highly significant relationship between the LasR phenotype and the global exometabolic profile of the clinical strains. Furthermore, our analysis identified several metabolites whose production appears to be linked to LasR expression. These findings were validated using a loss of function/gain of function approach. This connection between lasR genetic expression, the chronic adaptation of P.aeruginosa to the CF lung environment and the generation of traceable metabolic markers highlights a potential avenue for diagnosing and monitoring respiratory infections caused by this pathogen.

10 January 2026 in Water
Verified
Journal Article
Open access
PDF file
ADAntonio Doménech-Sánchez
Antonio Doménech-Sánchez
ÀGÀlex González-Alsina
Àlex González-Alsina
MMMargalida Mateu-Borrás
Margalida Mateu-Borrás
SASebastián Albertí
Sebastián Albertí
Pseudomonas aeruginosa is a key indicator of hygienic and operational deficiencies in swimming pools, particularly in tourist facilities with high and variable user loads. This study reports the results of a four-year regulatory surveillance program (2016–2019) assessing P. aeruginosa contamination in tourist swimming pools in Andalusia, Spain. The program involved 14 hotels and 58 unique installations. A total of 2053 water samples collected from different installation types (outdoor and indoor pools, whirlpools, and cold-plunge pools) were analyzed using standardized ISO methods within the framework of Spanish legislation, and prevalence comparisons were based on proportion tests. The overall prevalence of P. aeruginosa was 5.1%, with marked differences among installation types, reflecting both variation in contamination rates and unequal sampling intensity. Whirlpools consistently showed the highest contamination rates, whereas indoor pools and cold-plunge pools exhibited lower prevalence. No significant differences were observed between chlorine- and bromine-treated pools, and contaminated samples were detected across the full range of disinfectant concentrations, including values within regulatory limits. Temporal analysis revealed that apparent seasonal peaks were installation-dependent rather than reflecting a uniform seasonal trend. Winter detections were confined to indoor pools and whirlpools, which remain operational year-round, while outdoor pools and cold-plunge pools were underrepresented during the low season due to reduced sampling. A marked increase in prevalence was observed in 2019, driven mainly by summer months and high-risk installations; however, this rise was not directly associated with tourist volume and does not support causal inference. These findings highlight the importance of installation-specific and operational factors in shaping P. aeruginosa contamination patterns. The study underscores the need for targeted surveillance strategies focusing on high-risk installations and for cautious interpretation of seasonal patterns in datasets derived from routine regulatory monitoring.

16 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ADAntonio Doménech-Sánchez
Antonio Doménech-Sánchez
ÀGÀlex González-Alsina
Àlex González-Alsina
MMMargalida Mateu-Borrás
Margalida Mateu-Borrás
SASebastián Albertí
Sebastián Albertí
Tourist swimming pools are complex aquatic systems where operational failures can favour microbial growth and exposure to opportunistic pathogens. We conducted a four‑year surveillance (2016–2019) in hotel pools across Andalusia (Spain), analysing 2,053 water samples under Spanish regulation (Royal Decree 742/2013) with ISO methods (Pseudalert®/ISO 16266‑2 for Pseudomonas aeruginosa and Colilert‑18/ISO 9308‑2 for Escherichia coli). Overall non‑compliance reached 24.8%, and 2.0% of samples triggered immediate pool closure, most frequently due to P. aeruginosa. The bacterium was detected in 5.1% of samples, with heterogeneous distribution among installations: whirlpools (7.9%) > indoor pools (6.4%) > outdoor pools (4.5%) > cold wells (2.9%). No significant association was observed between use by children and P. aeruginosa detection (p > 0.05). Contamination occurred under both chlorine and bromine disinfection, with comparable prevalence (p = 0.18), and overlapping residual distributions indicated that single‑point disinfectant measurements alone did not predict contamination. Seasonality showed a bimodal pattern with winter (January) and summer (August) peaks, and prevalence markedly increased in 2019 compared with prior years. These findings highlight that P. aeruginosa contamination in tourist pools is driven less by momentary disinfectant levels than by structural and operational determinants (e.g., biofilm‑prone niches and hydraulic performance), underscoring the need for continuous surveillance, hydraulic optimization, routine mechanical cleaning, and robust monitoring across all seasons.

18 June 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGM. Trinidad García-Barceló
M. Trinidad García-Barceló
BMBiel Martorell
Biel Martorell
AGAlexandre González-Alsina
Alexandre González-Alsina
ADAntonio Doménech-Sánchez
Antonio Doménech-Sánchez
RGRosa M. Gomila
Rosa M. Gomila
MMMargalida Mateu-Borràs
Margalida Mateu-Borràs
Pseudomonas aeruginosa is an opportunistic respiratory pathogen frequently affecting hospitalized patients and individuals with chronic lung diseases such as cystic fibrosis (CF), bronchiectasis, and chronic obstructive pulmonary disease (COPD). Current diagnostic methods for airway infection are often invasive or lack sensitivity, highlighting the need for non-invasive approaches. Volatile organic compounds (VOCs) released by microbes represent promising candidates for non-invasive detection of respiratory pathogens. In this study we characterized the volatilome of clinical P. aeruginosa isolates and identified candidate VOC markers associated with bacterial metabolism. An untargeted volatilomics workflow based on gas chromatography–mass spectrometry (GC–MS) was applied to profile the in vitro VOCs produced by 48 clinical P. aeruginosa isolates associated with acute and chronic respiratory infections. We identified three previously unrecognized VOCs consistently produced by all isolates, suggesting conserved metabolic features of P. aeruginosa. Comparative analysis revealed marked metabolic differences between infection phenotypes: chronic isolates produced higher levels of aliphatic volatiles, whereas acute isolates were enriched in aromatic compounds, particularly acetophenone. Longitudinally sampled clonally related isolates from CF patients exhibited distinct and evolving volatilomic signatures, indicating metabolic adaptation over the course of chronic infection. Because LasR dysfunction is common during chronic airway colonization, we further assessed its impact on VOC production. LasR-functional isolates produced elevated levels of sulfur-containing VOCs and specific ketones, while LasR-deficient isolates displayed increased alcohol production. Overall, our findings show that isolates from chronic infections are associated with a shift from aromatic to aliphatic VOCs compared to acute isolates, and highlight volatilomics as a powerful tool for probing metabolic adaptation in P. aeruginosa and for identifying candidate VOC markers associated with infection-related phenotypes.